How PKCα and PKCδ Regulate Shedding of Heparin Binding-EGF
Author Information
Author(s): Marie Kveiborg, Rachael Instrell, Christina Rowlands, Michael Howell, Peter J. Parker
Primary Institution: Cancer Research UK, London Research Institute
Hypothesis
The study investigates the molecular mechanisms of PKC-dependent ectodomain shedding of EGFR-ligands.
Conclusion
The study found that PKCα and PKCδ regulate the shedding of HB-EGF through separate but cooperative pathways.
Supporting Evidence
- PMA treatment triggers a rapid release of HB-EGF mediated by ADAM17.
- PKCα specifically regulates PMA-induced shedding of HB-EGF.
- PKCδ and ERK influence both constitutive and inducible shedding of HB-EGF.
- Combined inactivation of PKCα and PKCδ results in total blockage of HB-EGF shedding.
Takeaway
This study shows that two proteins, PKCα and PKCδ, help control how a growth factor is released from cells, which is important for cancer growth.
Methodology
The study used a cell-based system to analyze PMA-induced shedding of HB-EGF and employed various inhibitors and siRNA for specific protein knockdown.
Limitations
The study does not explore the role of other potential ADAMs in HB-EGF shedding beyond ADAM17.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website